医学
痛风
内科学
硫唑嘌呤
耐火材料(行星科学)
关节炎
来氟米特
类风湿性关节炎
天体生物学
物理
疾病
作者
Robert T. Keenan,John K. Botson,Karim R. Masri,Lissa Padnick‐Silver,Brian LaMoreaux,John A. Albert,Michael H. Pillinger
标识
DOI:10.1016/j.semarthrit.2021.01.005
摘要
Published reports suggest that immunomodulation co-therapy has the potential to markedly improve pegloticase responder rates in patients with uncontrolled gout.
科研通智能强力驱动
Strongly Powered by AbleSci AI